...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Biochemical and functional analysis of corticotropin releasing factor purified from an aqueous extract of human placenta used as wound healer
【24h】

Biochemical and functional analysis of corticotropin releasing factor purified from an aqueous extract of human placenta used as wound healer

机译:用作伤口愈合液的人胎盘水质提取物纯化的皮质素释放因子的生化和功能分析

获取原文
获取原文并翻译 | 示例
           

摘要

Human placental extract constitutes of innumerable therapeutically important components mostly used in wound healing arising from the skin and burn injuries. However, there is still some bioactive present in the placental extracts yet to be characterized to better under the complex process of wound healing mediated by the placental extract. In this study, the presence of corticotropin releasing factor (CRF) in an aqueous extract of human placenta was detected and quantified by dot blot and CRF-ELISA immunoassay kit respectively. Subsequently, it was purified by immuno-affinity chromatography and quantified as 0.45 +/- 0.05 mu g of CRF per ml of placental extract where its molecular weight found to be 4.78 kDa by MALDI-TOF. To study functional analysis of CRF, an in vitro WI -38 lung fibroblast cell scratch wound model was used which indicated proliferation, motility of cells after treatment with purified CRF. Moreover, reduction in apoptosis rate of cells during closure of wound was observed from microscopy studies and FACS analysis. Also, Antalarmin, an antagonist of CRF type 1 receptor inhibited the wound closure potency of the purified component. Faster healing of wound with an elevation of IL-6 and TGF-beta(3 during early stages of repair by placental CRF was observed on excision rat model. The process of healing was accompanied by the decrease in the level of TNF-alpha and IFN-gamma. (C) 2017 Elsevier B.V. All rights reserved.
机译:人胎盘提取物构成无数治疗性重要组成部分,主要用于皮肤和烧伤伤害的伤口愈合。然而,胎盘提取物中仍然存在一些生物活性存在,但在胎盘提取物介导的伤口愈合的复杂过程下表现出更好的表征。在该研究中,通过点印迹和CrF-ELISA免疫测定试剂盒检测和定量人胎盘水提取物中的皮质脂素释放因子(CRF)的存在。随后,通过免疫亲和力色谱法纯化,并将其定量为0.45 +/-0.05μg/ ml胎盘提取物,其中其分子量为4.78kDa,通过MALDI-TOF。为了研究CRF的功能分析,使用了一种体外Wi -38肺成纤维细胞划痕伤口模型,其指示在用纯化的CRF处理后细胞的增殖,细胞的运动。此外,从显微镜研究和FACS分析观察到伤口闭合期间细胞凋亡率的降低。此外,Antalarmin,CRF 1型受体的拮抗剂抑制了纯化组分的伤口闭合效力。在切除大鼠模型上观察到IL-6和TGF-Beta升高的伤口愈合更快地愈合(胎盘CRF修复期间3阶段。愈合过程伴随着TNF-alpha和IFN水平的减少伴随着减少-Gamma。(c)2017 Elsevier BV保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号